Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT01528826

Unknown

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial (NVBOX)

Breast Cancer
NCT01276769

Unknown

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Triple Negative Breast Cancer
NCT00251329

Unknown

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

Breast Cancer
NCT07419971

Enrolling by invitation

Influencing Factors and Mechanisms of Capsular Contracture After Prosthesis Reconstruction in Patients With Breast Cancer

Breast Reconstruction | Breast Cancer Females
NCT07005583

Not yet recruiting

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Triple-Negative Breast Cancer (TNBC)
NCT06217874

Recruiting

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

Breast Carcinoma | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma
NCT04906369

Suspended

Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
NCT04256941

Terminated

Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma
NCT03854903

Completed

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Metastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast Cancer
NCT04290897

Completed

Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8
NCT03786354

Active, not recruiting

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer AJCC v8
NCT07601152

Not yet recruiting

Clinical and Biological Study of Early-onset Breast Cancer and the Influence of the Reproductive Cycle on the Aggressiveness of the Disease (ARTEMIS)

Breast Cancer
NCT07366840

Not yet recruiting

RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure (BRIGHT)

Metastatic Breast Cancer | HER2-positive Breast Cancer
NCT07297134

Recruiting

PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer (PTEN-miR-MBC)

Breast Cancer | Metastatic Breast Cancer | miRNAs | PTEN
NCT07260188

Recruiting

Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy (PDO-Neo01)

Invasive Breast Cancer
NCT07195227

Recruiting

Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer (CADILLAC)

Breast Cancer | Hormon Receptor Positive Breast Cancer
NCT07136974

Not yet recruiting

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

Breast Cancer | HER2 + Breast Cancer
NCT07103447

Not yet recruiting

Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC

Breast Cancer - Female
NCT07065435

Recruiting

RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

HER2 + Breast Cancer
NCT07037537

Recruiting

Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat Transplantation

Breast Cancer Patients
NCT07037576

Recruiting

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Breast Cancer Patients
NCT06902935

Not yet recruiting

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Breast Cancer Screening
NCT06846060

Not yet recruiting

A Mindfulness-Based Self-Compassion Program

Breast Cancer Survivor
NCT06734533

Recruiting

Anlotinib-based Combination Therapy in Patients with Hormone Receptor-positive（HR+） Metastatic Breast Cancer(MBC) .

HR+ Breast Cancer
NCT06835400

Not yet recruiting

Oral Paclitaxel + Encequidar vs IV Paclitaxel in Treatment of HER2 Negative Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06781281

Recruiting

NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.

Breast Cancer Invasive
NCT06725940

Recruiting

GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer (GzmB-PET4BC)

Breast Cancer Invasive
NCT06724835

Recruiting

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Advanced Breast Cancer
NCT06716073

Recruiting

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Breast Cancer Invasive
NCT06671730

Recruiting

Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer (SDOTS)

Breast Cancer Survivor
NCT06656624

Recruiting

Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)

Advanced Breast Cancer
NCT06638307

Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Advanced Breast Cancer
NCT06603597

Recruiting

HER2-positive Breast Cancer Registry (PRO-HER2)

HER2 + Breast Cancer
NCT06537674

Not yet recruiting

Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer

HER2+ Breast Cancer
NCT06478589

Recruiting

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Breast Cancer Survivorship
NCT06471452

Recruiting

To Live Better After Breast Cancer Treatment

Breast Cancer Survivorship
NCT06445738

Recruiting

Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) (PROSPECTIVE)

Breast Cancer | Breast Cancer Female
NCT06417801

Recruiting

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling. (Pangeia-2)

Metastatic Breast Cancer
NCT06380751

Recruiting

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer (EvoPAR-BR01)

Advanced Breast Cancer
NCT06377852

Recruiting

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Metastatic Breast Cancer
NCT06375707

Recruiting

Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced Breast Cancer
NCT06336928

Recruiting

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis

Breast Carcinoma
NCT06301438

Recruiting

Dalpiciclib in HR+/HER2- ABC

Advanced Breast Cancer
NCT06193525

Recruiting

FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test (FUTURE)

Advanced Breast Cancer
NCT06185855

Not yet recruiting

A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in Ultrasonography

Breast Cancer | Breast Cancer Diagnosis
NCT06110793

Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Metastatic Breast Cancer
NCT06100263

Recruiting

Breast Cancer Resiliency Through Exercise Program (B-REP) (B-REP)

Breast Cancer Female
NCT05998655

Recruiting

Tele-nursing Practices Based on Technological Competence Theory in Breast Cancer Patients

Breast Cancer Female
NCT05939310

Recruiting

Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study (MARGIN-2)

Breast Cancer | Breast Cancer Invasive
NCT05910398

Recruiting

Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer (CORINNE-PI)

Breast Cancer Invasive

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations